loading

Finanzdaten der Rocket Pharmaceuticals Inc-Aktie (RCKT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
6.47%
67.38
63.28 65.43 68.76 62.19
Interest Income/Expense
0.21%
0.471
0.47 0.469 0.468 0.468
Operating Income/Loss
6.47%
-67.38
-63.28 -65.43 -68.76 -62.19
Income/Loss From Continuing Operations Before Tax
4.01%
-62.05
-59.66 -61.90 -65.70 -58.34
Income/Loss From Continuing Operations After Tax
4.01%
-62.05
-59.66 -61.90 -65.70 -58.34
Net Income/Loss
4.01%
-62.05
-59.66 -61.90 -65.70 -58.34
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,876%
93.55
3.1433 82.64 80.47 79.45
Diluted Average Shares
2,876%
93.55
3.1433 82.64 80.47 79.45
Basic Earnings Per Share
6.45%
-0.66
-0.62 -0.75 -0.82 -0.73
Diluted Earnings Per Share
6.45%
-0.66
-0.62 -0.75 -0.82 -0.73
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$66.10
price down icon 2.65%
$73.33
price down icon 0.15%
$31.60
price up icon 0.06%
$18.91
price down icon 11.53%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 7.93%
Kapitalisierung:     |  Volumen (24h):